Ann: Phase 2 Clinical Trial For Treatment of Epilepsy Underway, page-3

Highlights:

 Phase 2 clinical trial of PTL101, MMJ’s investigational drug, now underway, following completion of successful Phase 1 trial in 2016

 Phase 2 clinical trial is aimed at measuring safety and efficacy of the PTL101 drug-beads for reducing seizures frequency in children with refractory epilepsy

 Successful Phase 2 clinical trial will be a major step towards commercial development of the PTL101 drug for epilepsy treatment

 Preparation for an additional Phase 2 study to treat spasticity related symptoms of multiple sclerosis patients utilising PTL201 is well advanced